Dermatology Drug Developer Can Tap $3M Of Ch. 11 Loan

By Vince Sullivan · November 21, 2023, 8:08 PM EST

Bankrupt drug developer Timber Pharmaceuticals Inc. received interim approval Tuesday to access a portion of its $13.9 million Chapter 11 financing package after adding protections for unsecured creditors at the request...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Trex Wind-down, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

November 17, 2023

Recent Articles By Vince

May 17, 2024
Healthcare Co. Sues Steward In Ch. 11 Over Military Contract
March 12, 2024
Breast Implant Co.'s $90M DIP OK'd With Creditor Protections
March 04, 2024
Hospital Operator Pushes For Ch. 11 Plan Confirmation
February 06, 2024
Cano Health DIP Gets Initial OK Without $23M Lender Fees
January 22, 2024
Skin Care Drug Co. Timber Gets OK For Ch. 11 Sale To Lender
January 10, 2024
US Trustee Calls SmileDirect Ch. 11 Deal An Improper Plan
December 06, 2023
GenesisCare Gets OK For $20M DIP Funding Hike
December 01, 2023
Alecto Health Can Continue With Subchapter V Designation
November 29, 2023
Alecto Health Co. Says Threshold Met For Subchapter V Status
November 20, 2023
Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan